These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9439643)

  • 21. A canine minidystrophin is functional and therapeutic in mdx mice.
    Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
    Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice.
    Gillis JM
    Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
    Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
    Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gene therapy to muscle diseases: perspective and issues on basic research].
    Takeda S
    Nihon Rinsho; 1997 Dec; 55(12):3114-9. PubMed ID: 9436420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
    Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
    Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
    Rafael JA; Brown SC
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
    Kapsa RM; Wong SH; Quigley AF
    Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dystrophin and utrophin expression in muscle tissues of DMD mouse model after transplantation treatment by bone marrow mesenchymal stem cells].
    Li Z; Zhang C; Xie YM; Chen GJ; Liu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):294-7. PubMed ID: 15266833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
    Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
    Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Future treatment modalities in Duchenne muscular dystrophy].
    Oron A; Shuper A; Shohat M
    Harefuah; 1998 Apr; 134(7):557-60. PubMed ID: 10909603
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice.
    Yamamoto K; Yuasa K; Miyagoe Y; Hosaka Y; Tsukita K; Yamamoto H; Nabeshima YI; Takeda S
    Hum Gene Ther; 2000 Mar; 11(5):669-80. PubMed ID: 10757347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene delivery to dystrophic muscle.
    Wells KE; McMahon J; Foster H; Ferrer A; Wells DJ
    Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle.
    Fujimori K; Itoh Y; Yamamoto K; Miyagoe-Suzuki Y; Yuasa K; Yoshizaki K; Yamamoto H; Takeda S
    Hum Gene Ther; 2002 Mar; 13(4):509-18. PubMed ID: 11874629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.
    Clemens PR; Kochanek S; Sunada Y; Chan S; Chen HH; Campbell KP; Caskey CT
    Gene Ther; 1996 Nov; 3(11):965-72. PubMed ID: 8940636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
    Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
    Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH; Sirsi SR; Latta DR; Lutz GJ
    Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
    Dalloz C; Claudepierre T; Rodius F; Mornet D; Sahel J; Rendon A
    Mol Cell Neurosci; 2001 May; 17(5):908-20. PubMed ID: 11358487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
    Krag TO; Gyrd-Hansen M; Khurana TS
    Acta Physiol Scand; 2001 Mar; 171(3):349-58. PubMed ID: 11412148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.